Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Ophiomics
Ophiomics is a clinical-stage medtech company focused on precision liver medicine, developing AI and genomics-powered diagnostic products for diagnosis, prognosis, treatment selection, and follow-up…
Ophiomics
Ophiomics is a clinical-stage medtech company focused on precision liver medicine, developing AI and genomics-powered diagnostic products for diagnosis, prognosis, treatment selection, and follow-up…
TL;DR
Headquarters: Lisboa, Portugal
Founded: 2015
Focus: AI + genomics diagnostics for precision liver medicine (IVD)
Certifications: ISO 13485 and ISO 9001
Notable product: HepatoPredict (CE-marked IVD kit)
Recent funding: Series A completed Jan 18, 2023 (lead: BlueCrow Capital)
Company Overview
Problem Domain
Early detection and personalized management of liver disease and liver cancer using omics and AI-driven diagnostics.
Founded
2015
Industry
Biotechnology
Tech Stack
Funding Track Record
€1,000,000
Seed tied to an EIC accelerator award
Series A announced as completed on Jan 18, 2023; described as covered by funds managed by BlueCrow Capital
Investor Signal
“BlueCrow Capital; European Innovation Council”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week